Form 8-K - Current report:
SEC Accession No. 0001104659-26-085061
Filing Date
2026-07-20
Accepted
2026-07-20 16:06:12
Documents
14
Period of Report
2026-07-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2620864d1_8k.htm   iXBRL 8-K 46968
2 EXHIBIT 10.1 tm2620864d1_ex10-1.htm EX-10.1 414409
3 EXHIBIT 99.1 tm2620864d1_ex99-1.htm EX-99.1 12263
7 GRAPHIC tm2620864d1_ex10-1img001.jpg GRAPHIC 6913
  Complete submission text file 0001104659-26-085061.txt   745133

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA elut-20260716.xsd EX-101.SCH 3008
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elut-20260716_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elut-20260716_pre.xml EX-101.PRE 22354
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2620864d1_8k_htm.xml XML 3099
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 261186718
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)